Home     About Us     Team     Products     News     Contact     FAQ     Account

PI3K Inhibitors

Aliqopa (copanlisib)

Copanlisib (trade name Aliqopa), is a drug which is approved by US FDA for the treatment of adult patients experiencing relapsed follicular lymphoma who have received at least two prior systemic therapies...Wikipedia



Manufacturer's Website: Aliqopa                                                                                                                                       Average retail cost: $4,300/vial

Zydelig (idelalisib)

Idelalisib (trade name Zydelig) is a drug used for the treatment of certain hematological malignancies...Wikipedia



Manufacturer's Website: Zydelig                                                                                                                                      Average retail cost: $10,900/month

Copyright 2006-2022 Automated Clinical Guidelines, LLC. All rights reserved.